Definium Therapeutics, Inc. (DFTX) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -353.79M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-353.79M | (m) |
| 2026-03-31 | (m) | $-237.54M | (m) |
| 2025-12-31 | (m) | $-183.79M | (m) |
| 2025-09-30 | (m) | $-168.10M | (m) |
| 2025-06-30 | (m) | $-114.52M | (m) |
| 2025-03-31 | (m) | $-77.63M | (m) |
| 2024-12-31 | (m) | $-108.68M | (m) |
| 2024-09-30 | (m) | $-97.80M | (m) |
| 2024-06-30 | (m) | $-102.04M | (m) |
| 2024-03-31 | (m) | $-125.32M | (m) |
| 2023-12-31 | (m) | $-95.73M | (m) |
| 2023-09-30 | (m) | $-76.77M | (m) |
| 2023-06-30 | (m) | $-75.33M | (m) |
| 2023-03-31 | (m) | $-63.16M | (m) |
| 2022-12-31 | (m) | $-56.80M | (m) |
| 2022-09-30 | (m) | $-68.72M | (m) |
| 2022-06-30 | (m) | $-69.43M | (m) |
| 2022-03-31 | (m) | $-97.73M | (m) |
| 2021-12-31 | (m) | $-93.04M | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | $-33.94M | (m) |
| 2019-12-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |